TrialHelicobacter2022

Optimized dual therapy for treatment-naive patients of Helicobacter pylori infection: A large-scale prospective, multicenter, open-label, randomized controlled study.

Ying-Ying Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.